Peptides - CMC development for NCE projects quickly explained
Bachem Bachem
648 subscribers
2,385 views
0

 Published On Feb 3, 2023

What does a successful drug development process entail?

Several critical phases must be completed to obtain market approval for a new drug and its commercial production. The active pharmaceutical ingredient and its formulated form must pass the preclinical and clinical phases I to III. After that, the New Drug Application must be filled, and then the API can be supplied commercially upon market approval.

Featuring Zina Zokouri, Business Development Manager, Global Business Development Europe, Bachem

Contact the experts today: https://www.bachem.com/contact/

---------------------------------------------------------------------------------------------------------------------------

About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.

The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

Learn more about our products and services at https://bit.ly/3LykCeY

show more

Share/Embed